May 23, 2011
HRSA Issues Proposed Rule on Exclusion of Orphan Drugs for Certain Covered Entities Under the 340B Program
Arnold & Porter Advisory
People
This site uses cookies to enhance functionality and performance. You may change your cookie settings at any time. If you do nothing, you are giving implied consent to the use of cookies on this website.